Harvard Apparatus Regenerative Technology Files 8-K
Ticker: HRGN · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1563665
| Field | Detail |
|---|---|
| Company | Harvard Apparatus Regenerative Technology, Inc. (HRGN) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, financial-statements
TL;DR
Harvard Apparatus Regenerative Tech filed an 8-K on July 14, 2025, detailing material agreements and equity sales.
AI Summary
On July 11, 2025, Harvard Apparatus Regenerative Technology, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The filing details are part of a Form 8-K submitted on July 14, 2025.
Why It Matters
This 8-K filing indicates significant corporate actions, including definitive agreements and equity sales, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to stock price volatility, especially those involving definitive agreements and equity sales.
Key Numbers
- 001-35853 — SEC File Number (Identifies the company's filing with the SEC.)
- 45-5210462 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Harvard Apparatus Regenerative Technology, Inc. (company) — Registrant
- July 11, 2025 (date) — Date of earliest event reported
- July 14, 2025 (date) — Date of report filing
- 001-35853 (company) — SEC File Number
- 45-5210462 (company) — IRS Employer Identification No.
FAQ
What type of material definitive agreement was entered into by Harvard Apparatus Regenerative Technology, Inc. on July 11, 2025?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into.
What was the purpose of the unregistered sales of equity securities mentioned in the filing?
The filing mentions unregistered sales of equity securities but does not provide details on the purpose or terms of these sales.
When was the Form 8-K filed with the SEC?
The Form 8-K was filed on July 14, 2025.
What is the principal business address of Harvard Apparatus Regenerative Technology, Inc.?
The principal business address is 84 October Hill Road, Suite 11, Holliston, MA 01746.
Has Harvard Apparatus Regenerative Technology, Inc. undergone any previous name changes?
Yes, the company was formerly known as Biostage, Inc. (name change effective March 31, 2016) and Harvard Apparatus Regenerative Technology, Inc. (name change effective December 4, 2012).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding Harvard Apparatus Regenerative Technology, Inc. (HRGN).